GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

Baxdrostat, a selective aldosterone synthase inhibitor, lowered BP and albuminuria in patients with uncontrolled hypertension ...

As the prevalence of both chronic kidney disease (CKD) and heart failure (HF) increases, therapies targeting shared pathways ...

Chronic kidney disease is a common complication of type 2 diabetes, but not everyone with diabetes develops it. Certain risk factors, like diabetic neuropathy and hypertension, can increase the chance ...

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally effective ...

A proinflammatory diet might increase anemia risk in patients with diabetic kidney disease. Anemia occurs more frequently in patients with diabetic kidney disease (DKD) who have a proinflammatory diet ...

Kidney disease is becoming a growing problem in developing countries, caused by an explosion in cases of diabetes and high blood pressure, experts say. As developing countries become increasingly ...

USA: Researchers have reported a potential risk of severe hypercalcemia when tirzepatide, a dual GIP and GLP-1 receptor ...

Arch acquires a new CKD platform that has the potential to produce next-generation CKD drugs for the pharmaceutical industryBased on a novel mechanism of action involving IL-32 and directly implicated ...

Chronic kidney disease (CKD) is a silent epidemic affecting thousands of Utahns. According to the Utah Department of Health and Human Services, 1 in 5 Utah resi ...